We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BLRX market cap is 17.91M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 4.8M | 6.86M | 5.39M | 4.94M |
| Operating Income | -12.36M | -18.57M | -4.82M | -5.77M | -5.39M |
| Net Income | -16.02M | -13.88M | -696k | 484k | -5.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 4.8M |
| Operating Income | -28.11M | -22.93M | -24.78M | -29.16M | -49.7M |
| Net Income | -25.45M | -30.02M | -27.05M | -24.95M | -60.61M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 52.86M | 63.93M | 51.6M | 64.6M | 52.74M |
| Total Liabilities | 39.72M | 50.7M | 38.54M | 50.62M | 44.24M |
| Total Equity | 13.13M | 13.22M | 13.06M | 13.98M | 8.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 53.57M | 47.29M | 81.39M | 76.38M | 63.93M |
| Total Liabilities | 20.19M | 25.26M | 13.3M | 25.54M | 50.7M |
| Total Equity | 33.38M | 22.03M | 68.09M | 50.84M | 13.22M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.6M | -22.61M | -14.11M | -25.44M | -35.26M |
| Investing | 21.84M | 1.44M | 16.69M | 8.04M | 18.22M |
| Financing | 3.32M | 15.06M | -894k | 22.99M | 21.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.67M | -23.21M | -23.57M | -26.24M | -22.61M |
| Investing | 5.26M | 16.67M | -38.22M | 4.01M | 1.44M |
| Financing | 19.19M | 17.87M | 57.75M | 20.44M | 15.06M |
| Market Cap | 17.91M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 79.94M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (3.93%) |
| Company Name | BioLineRx Ltd |
| Address |
modi’in technology park modi'in-maccabim-re'ut, center 7177871 |
| Website | https://www.biolinerx.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
